文献速递眼底病与葡萄膜炎神经眼科

高安动脉炎患者的眼部表现与血流:一项横断面研究

Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study.
PubMed 文献 · Br J Ophthalmol · 2018-08-27

该横断面研究纳入65例高安动脉炎(TAK)患者与30名健康对照,行风湿科与眼科评估及眼动脉(OA)和视网膜中央动脉(CRA)彩色多普勒超声。TAK患者OA和CRA阻力指数(RI)均升高,高血压视网膜病变与病程长相关,同侧桡动脉无脉可预测同侧眼部灌注减低。

要点

  • TAK患者眼动脉和视网膜中央动脉阻力指数较健康对照显著升高。
  • 同侧桡动脉无脉者同侧眼动脉阻力指数显著更高,提示眼部灌注减低。
  • 高血压视网膜病变患者病程显著更长,但本组无因缺血或新生血管并发症致视力丧失者。

核心结论

  • TAK患者存在眼动脉和视网膜中央动脉阻力指数升高,提示眼部灌注受损。
  • 同侧桡动脉无脉可预测同侧眼部灌注减低。
  • 本组TAK视网膜病变患病率低且无永久性视力丧失,可能与当前药物治疗管理改善有关。

研究设计与样本

  • 横断面研究,纳入65例TAK患者(女60例、男5例,平均年龄41.8±12.9岁)和30名健康对照(均为女性,平均年龄39.0±7.5岁)。
  • 所有患者接受详细风湿科与眼科评估,并用彩色多普勒超声评估眼动脉和视网膜中央动脉血流。

主要发现

  • 高血压视网膜病变占33.9%,Takayasu视网膜病变占6.2%。
  • 后囊下白内障或白内障手术史占15.4%。
  • 无患者因缺血或新生血管并发症发生视力丧失。
  • TAK患者眼动脉阻力指数升高(0.75 vs 0.66,p=0.002),视网膜中央动脉阻力指数升高(0.75 vs 0.67,p=0.001)。
  • 高血压视网膜病变患者病程显著更长(p=0.016);同侧桡动脉无脉者同侧眼动脉阻力指数显著更高(0.77 vs 0.68,p=0.031)。

临床怎么用

  • 对TAK患者应关注眼部灌注评估,尤其存在桡动脉无脉时需警惕同侧眼部血流减低。
  • TAK患者需监测高血压视网膜病变及白内障等眼部并发症,并结合全身病情进行管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Takayasu arteritis (TAK) is a chronic granulomatous vasculitis that can lead to ischaemic ocular complications. We aimed to document ocular complications, ocular blood flow and the association of them with systemic clinical findings in TAK. MATERIAL AND METHODS: We included 65 patients with TAK (60 female, 5 male, mean age: 41.8±12.9 years) and 30 healthy subjects (30 female, mean age: 39.0±7.5 years) in this study. All of the patients had a detailed rheumatological and ophthalmological evaluation. Ocular blood flow in ophthalmic artery (OA) and central retinal artery (CRA) was evaluated with colour Doppler ultrasonography. RESULTS: Hypertensive retinopathy was observed in 33.9%, and Takayasu retinopathy was observed in 6.2% of patients. Posterior subcapsular cataracts or a history of cataract surgery was seen in 15.4% of the cases. None of the patients experienced visual loss due to ischaemic or neovascular complications. Patients with TAK had increased resistivity index (RI) in ophthalmic artery (0.75 vs 0.66, p=0.002) and CRA (0.75 vs 0.67, p=0.001). Patients with hypertensive retinopathy had significantly longer disease duration (p=0.016). Ophthalmic artery RI was significantly higher in patients with ipsilateral radial artery pulselessness compared with patients without (0.77 vs 0.68, p=0.031). CONCLUSION: This study reported the lowest prevalence of Takayasu retinopathy and is the only series without permanent visual loss. We documented for the first time that radial artery pulselessness can predict reduction of ipsilateral ocular perfusion. We believe that better management of TAK with current medications reduced ocular complication rates.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Esen F, Ergelen R, Alibaz-Öner F, et al. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study. Br J Ophthalmol. 2018. PMID: 30150277. doi:10.1136/bjophthalmol-2018-312580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。